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rotaxanes: solvent-induced macrocycle
translocation and/or unthreading†
Radoslav Z. Pavlovic´,a Mira S. Bjelakovic´b and Dragana R. Milic´*a
The synthesis, characterization and behaviour of two novel Leigh-type amide [2]rotaxanes are reported.
NMR study shows that fullerosteroidal and disteroidal rotaxanes occur in a peptide co-conformation in
CDCl3. [D6]DMSO induces fast unthreading of disteroidal rotaxane, which includes steroid co-
conformers as intermediates. On the other hand, fullerosteroidal rotaxane undergoes predominantly
a shuttling process occupying the stacked co-conformation, whereas unthreading is very slow in
comparison with its disteroidal analogue (25% after 7 days). Moreover, organogelation and self-
organization properties were studied. It was found that disteroidal rotaxane is an organogelator and its
SEM image shows that it forms a branched ﬁlm-like network in a PhMe/EtOAc 1 : 1 mixture.1. Introduction
Rotaxanes are mechanically interlocked supramolecular archi-
tectures composed of one or more linear moieties (thread, axle)
surrounded by macrocyclic ring(s) (wheel) and suﬃciently large
stopper groups positioned at the axle termini in order to prevent
the dissociation process.1 Due to their abacus like structure,2
rotaxanes have attracted great attention in studies of non-
covalent bonding interactions, as well as in wide ranges of
applied research. Such compounds have proven to be valuable
in biomedical exploration (enzyme-sensitive rotaxane-based
propeptides,3 supramolecular nanovalves as anticancer drug
carriers,4 rotaxanes with oligomeric axles as intracellular
transport agents,5 squaraine-rotaxanes as molecular probes for
in vitro and in vivo uorescence cell imaging6), but also as
components of nanoelectrochemical devices.7 Besides careful
design based on a choice of axle–wheel interactions (hydro-
phobic, ionic, p–p stacking, hydrogen bonding, metal–ligand
coordination) and consequent rational subunit selection, the
development of template-directed synthetic strategies1a,8
expanded the possibility to obtain a large number of rotaxanes.
The notable mobility of the macrocyclic ring within the supra-
molecular system enables its rotation around the thread1a and
translational movement along the axle allows reversible (shut-
tling)9 or irreversible (unthreading) movement.10 In addition,ry, Studentski trg 12-16, 11158 Belgrade,
ry, Technology and Metallurgy, Center for
erbia
SI) available: Tabular representation of
ass spectra of compounds 3 and 4. See
3the shuttling process in rotaxanes possessing two or more
diﬀerent stationary units causes co-conformational isom-
erism,11 and the predominance of one of the translational
isomers in response to external stimuli. The position of the ring
component of the molecular shuttle can be controlled by vari-
ation of the electrochemical potential,12 pH,13 illumination,14
solvent,9 or by cooperative eﬀects of various driving forces15
which allow the manipulation of binding aﬃnities. Eﬃcient
switching without further chemical transformations can be
performed using solvents of diﬀerent polarity (dichloro-
methane and dimethyl sulfoxide), as described by the examples
of two hydrogen bond-assembled fullerene-stoppered rotax-
anes.2,16 However, poor solubility of Leigh-type fullerene-
stoppered rotaxanes is one of the major obstacles to their
application.2,17 It was also observed that the presence of the
steroidal subunit in mechanically interlocked molecules played
an essential role in their self-organization to more complex,
morphologically well dened architectures.18
Willing to examine individual as well as mutual eﬀects of
steroidal and fullerenic stoppers on properties of mechanically
interlocked systems, here we describe the template-directed
synthesis and detailed characterization of two novel hydrogen
bond assembled rotaxanes – disteroidal, with pregnenolone-
derived stoppers, and fullerene-pregnenolone stoppered. Their
shuttling/unthreading behaviour in solvents of diﬀerent
polarity as well as the self-organization process are also exam-
ined and discussed.2. Experimental
General information
The amine-TFA salt 1,19 fulleropyrrolidinic acid 2a,20 pregnen-
olone hemisuccinate 2b21 and the thread 3a19 were synthesizedThis journal is © The Royal Society of Chemistry 2016
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View Article Onlineaccording to the literature procedures. Chloroform and trie-
thylamine (TEA) were dried by reuxing with P2O5 and with
CaH2, respectively, and distilled prior to use. Flash column
chromatography (FCC) and dry-column ash chromatography
(DCFC) were carried out with Merck silica gel 0.04–0.063 mm
and 0.015–0.04 mm, respectively. Thin layer chromatography
(TLC) was carried out on precoated silica gel 60 F254 plates.
Melting points were determined on a Digital melting point
WRS-1B apparatus and are uncorrected. IR spectra (ATR) were
recorded with a Perkin-Elmer-FT-IR 1725X spectrophotometer; n
values are given in cm1. 1H and 13C NMR spectra were recorded
with Varian Gemini 200 (1H at 200 MHz, 13C at 50 MHz) and
Bruker Avance spectrometers (1H at 500 MHz, 13C at 125 MHz).
Chemical shis (d) are expressed in ppm and coupling
constants (J) in Hz. TMS was used as an internal reference. The
homonuclear 2D (DQF-COSY) and the heteronuclear 2D 1H–13C
spectra (HSQC, HMBC) were recorded with the usual settings.
UV spectra were recorded with a GBC-Cintra 40 UV/Vis spec-
trophotometer. The high-resolution MS spectra were taken with
Agilent 6210 LC ESI-MS TOF and LTQ Orbitrap XL spectrome-
ters. Standard steroidal numbering was used together with
abbreviations for 4-aminobutanoic and succinate fragments
(GABA and Succ, respectively). Labels of the peptide/diamide
moieties and the macrocycle ring in threads and rotaxanes are
given in Scheme 2. SEM: the morphology investigations were
carried out with SEM, using a JEOL JSM-840A instrument, at an
acceleration voltage of 30 kV. The dried samples obtained from
a drop of dilute solutions of rotaxanes 4a (0.1 mM in CHCl3) and
4b (0.1 mM in PhMe/EtOAc 1 : 1, v/v) were deposited on the
surface of a Si substrate (5  5 mm) and le overnight to slowly
evaporate in a glass Petri dish (diameter 10 cm) under a PhMe
atmosphere at room temperature. The investigated samples
were gold sputtered in a JFC 1100 ion sputter device and then
subjected to SEM observations.
Thread 3a.19 UV/Vis (CHCl3): lmax(3) ¼ 430 nm (2.33  103
mol1 dm3 cm1); 1H NMR (500 MHz, [D6]DMSO): d¼ 8.11 (br t,
J ¼ 5.0 Hz, 1H, NH(Gly)), 7.83 (br t, J ¼ 5.5 Hz, 1H, NH(GABA)),
5.34 (m, 1H, HC(6)), 4.49 (m, 1H, HC(3)), 4.45 (s, 4H, H2C(pyrr)),
3.78 (br d, J ¼ 5.0 Hz, 2H, H2C(Gly)), 3.16 (q, J ¼ 6.5 Hz, 2H,
H2C(40)), 3.13 (t, J ¼ 7.0 Hz, 2H, H2C (400)), 2.54 (m, 3H, H2C(200)
and HC(17)), 2.29 (m, 4H, H2C(20) and H2C(4)), 2.19 (quint, J ¼
7.0 Hz, 2H, H2C(300)), 2.08 (s, 3H, H3C(21)), 2.06 (m, 1H, HC(16)),
2.02 (m, 1H, HC(12)), 1.95 (m, 1H, HC(7)), 1.85 (m, 1H, HC(1)),
1.81 (m, 1H, HC(2)), 1.72 (m, 2H, H2C(30)), 1.64 (m, 1H, HC(15)),
1.60 (m, 1H, HC(11)), 1.58 (m, 1H, HC(16)), 1.56 (m, 1H, HC(2)),
1.55 (m, 1H, HC(7)), 1.43 (m, 5H, HC(8), HC(11) and HC(12)),
1.16 (m, 2H, HC(14) and HC(15)), 1.00 (m, 1H, HC(9)), 0.98 (s,
3H, H3C(19)), 0.55 (s, 3H, H3C(18));
13C NMR (125 MHz, [D6]
DMSO): d ¼ 208.2 (C(20)), 172.7 (C(100)), 171.9 (C(10)), 169.1
(CO(Gly)), Cfull (155.2, 146.7, 145.9, 145.7, 145.5, 144.8, 144.7,
144.1, 142.6, 142.1, 141.8, 141.6, 141.3, 139.5, 135.8), 139.3
(C(5)), 121.9 (C(6)), 73.1 (C(3)), 70.5 (Cfull-sp
3), 67.1 (C(pyrr)),
62.7 (C(17)), 56.1 (C(14)), 53.6 (C(400)), 49.3 (C(9)), 43.3 (C(13)),
42.3 (C(Gly)), 38.1 (C(12)), 37.9 (C(40)) 37.7 (C(4)), 36.5 (C(1)),
36.1 (C(10)), 33.4 (C(200)), 31.3 (C(8)), 31.1 (C(7)), 27.4 (C(2)), 24.5
(C(300)), 24.3 (C(15)), 24.0 (C(30)), 22.3 (C(16)), 20.6 (C(11)), 19.0
(C(19)), 12.9 (C(18)).This journal is © The Royal Society of Chemistry 2016Thread 3b. To an ice bath cooled solution of the TFA salt 1
(135 mg, 0.236 mmol, 1 equiv.) in DCM (10 mL), pregnenolone
hemisuccinate 2b (147 mg, 0.354 mmol, 1.5 equiv.), TEA (30 mg,
41 mL, 0.295 mmol, 1.25 equiv.), and HOBT (58 mg, 0.378 mmol,
1.6 equiv.) were added. A solution of DCC (78 mg, 0.378 mmol,
1.6 equiv.) in DCM (5 mL) was added dropwise over 2 h and the
reaction mixture was stirred for 24 h. The solvent was evapo-
rated in vacuo and the residue chromatographed by DCFC on
SiO2 column using PhMe/EtOAc/MeOH 5 : 5 : 2 to obtain 3b as
a colourless oil (128 mg, 63%), which was precipitated from the
DCM solution with n-hexane. Rf ¼ 0.54 (PhMe/EtOAc/MeOH
5 : 5 : 1); mp 119–120 C; IR: ~n ¼ 3305, 3079, 2941, 1729, 1707,
1650, 1553, 1440, 1358, 1253, 1177, 1025 cm1; 1H NMR (500
MHz, CDCl3): d ¼ 6.79 (t, J ¼ 6.0 Hz, 1H, NH(GABA)), 6.47 (t, J ¼
5.5 Hz, X part of ABX system, 1H, NH(Gly)), 5.37 (t, J ¼ 5.0 Hz,
2H, HC(6)), 4.60 (m, 2H, HC(3)), 3.93 (two AB quartets, AB part
of ABX system, J(AB) ¼ 15 Hz, J(AX, BX) ¼ 5.5 Hz, 2H, H2C(Gly)),
3.29 (q, J ¼ 7.0 Hz, 2H, H2C(4)-GABA), 2.70 (dt, J ¼ 2.0 and 6.5
Hz, 2H, H2C(3)-succ), 2.53 (two t, 2H, J¼ 9 Hz, HC(17)), 2.49 (t, J
¼ 6.5 Hz, 2H, H2C(2)-succ), 2.33 (t, J¼ 10 Hz, 2H, H2C(2)-GABA),
2.31 (m, 4H, HC(4)), 2.17 (m, 2H, HC(16)), 2.12 (s, 6H, H3C(21)),
2.05 (m, 2H, HC(12)), 2.00 (m, 2H, HC(7)), 1.88 (m, 2H, HC(1)),
1.86 (m, 2H, HC(2)), 1.84 (quint, J ¼ 10 Hz, 2H, H2C(3)-GABA),
1.69 (m, 2H, HC(15)), 1.65 (m, 2H, HC(16)), 1.61 (m, 2H,
HC(11)), 1.58 (m, 2H, HC(2)), 1.57 (m, 2H, HC(7)), 1.49 (m, 2H,
HC(8)), 1.48 (m, 2H, HC(11)), 1.45 (m, 2H, HC(12)), 1.21 (m, 2H,
HC(15)), 1.15 (m, 2H, HC(14)), 1.12 (m, 2H, HC(1)), 1.02 (s, 6H,
H3C(19)), 1.01 (m, 2H, HC(9)), 0.63 (s, 6H, H3C(18));
13C NMR
(125 MHz, CDCl3): d ¼ 209.5 (C(20)), 172.8 (CO-succ, ester)),
172.7 (CO(GABA)), 172.1 (CO-succ, amide), 169.0 (CO(Gly)),
139.6 and 139.5 (C(5)), 122.4 (C(6)), 74.6 and 74.0 (C(3)), 63.6
(C(17)), 56.8 (C(14)), 49.9 and 49.8 (C(9)), 43.9 (C(13)), 43.3
(C(Gly)), 39.0 (C(4)-GABA), 38.8 (C(12)), 38.0 (C(4)), 36.9 (C(1)),
36.6 (C(10)), 32.0 (C(2)-GABA)), 31.8 (C(8)), 31.7 (C(7)), 31.5
(C(21)), 30.9 (C(2)-succ), 29.8 (C(3)-succ), 27.7 (C(2)), 24.5 (C(3)-
GABA), 24.4 (C(15)), 22.8 (C(16)), 21.0 (C(11)), 19.3 (C(19)), 13.2
(C(18)); 1H NMR (500 MHz, [D6]DMSO): d ¼ 8.16 (t, J ¼ 6.0 Hz,
1H, NH(Gly)), 7.68 (t, J ¼ 6.0 Hz, 1H, NH (GABA)), 5.33 (m, 2H,
HC(6)), 4.45 (m, 2H, HC(3)), 3.61 (d, J ¼ 5.5 Hz, 2H, H2C(Gly)),
3.06 (q, J¼ 6.5 Hz, 2H, H2C(4)-GABA), 2.56 (two t, J¼ 9.0 Hz, 2H,
HC(17)), 2.49 (t, J ¼ 6.5 Hz, 2H, H2C(3)-succ), 2.39 (t, J ¼ 6.5 Hz,
2H, H2C(2)-succ), 2.25 (bt, J ¼ 7.5 Hz, 6H, H2C(4) and H2C(2)-
GABA), 2.05 (s, 6H, H3C(21)), 2.02 (m, 2H, HC(16)), 2.00 (m,
2H, HC(12)), 1.94 (m, 2H, HC(7)), 1.84 (m, 2H, HC(1)), 1.75 (m,
2H, HC(2)), 1.63 (quint, J ¼ 7.0 Hz, 2H, H2C(3)-GABA), 1.61 (m,
2H, HC(15)), 1.56 (m, 4H, HC(11), HC(16)), 1.54 (m, 4H, HC(2),
HC(7)), 1.42 (m, 2H, HC(12)), 1.40 (m, 4H, HC(8), HC(11)), 1.14
(m, 4H, HC(14), HC(15), 1.06 (m, 2H, HC(1)), 0.96 (m, 2H,
HC(9)), 0.96 (s, 6H, H3C(19)), 0.52 (s, 6H, H3C(18));
13C NMR
(125 MHz, [D6]DMSO): d ¼ 208.8 (C(20)), 172.2 (CO-succ, ester;
CO-GABA), 171.5 (CO-succ, amide), 169.1 (CO(Gly), 139.7 and
139.6 (C(5)), 122.1 and 122.0 (C(6)), 73.4 and 73.3 (C(3)), 62.7
(C(17)), 56.1 (C(14)), 49.4 (C(9)), 43.4 (C(13)), 42.3 (C(Gly)), 38.0
(C(12)), 37.9 (C(4)-GABA), 37.8 and 37.7 (C(4)), 36.6 (C(1)), 36.2
(C(10)), 31.4 (C(8) and C(7)), 31.3 (C(21)), 31.2 (C(2)-GABA), 29.9
(C(2)-succ), 29.4 (C(3)-succ), 27.4 (C(2)), 24.6 (C(3)-GABA), 24.1RSC Adv., 2016, 6, 37246–37253 | 37247
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View Article Online(C(15)), 22.4 (C(16)), 20.7 (C(11)), 19.1 (C(19)), 13.0 (C(18));
HRMS (ESI-TOF) (m/z): calcd for C52H77N2O8 (M + H)
+: 857.5674,
found: 857.5664.
Rotaxane 4a. A solution of p-xylenediamine (135 mg, 0.988
mmol) in anh. CHCl3 (42 mL) and a separate solution of iso-
phthaloyl dichloride (200 mg, 0.988 mmol) in anh. CHCl3 (42
mL) were simultaneously added dropwise over 4 h to a stirred
solution of the thread 3a (85 mg, 0.066 mmol) and dry TEA (200
mL, 1.403 mmol) in dry CHCl3 (25 mL) under Ar. Aer the
addition, the reaction mixture was stirred overnight at ambient
temperature. The mixture was ltered through Celite, evapo-
rated to dryness and chromatographed on silica gel by FCC. The
pure unconsumed thread 3a (68 mg, 80%) was eluted with
PhMe/EtOAc/MeOH 10 : 10 : 3 while the mixture of rotaxane
and free macrocycle (14 mg) was eluted with PhMe/EtOAc/
MeOH 10 : 10 : 7 and further separated by size exclusion chro-
matography on Sephadex G-25. Sephadex G-25 (10 g) was sus-
pended in CHCl3 (stabilized with 1% EtOH), le to swell
overnight and the solution of the mixture of 4a and free mac-
rocycle (14 mg) in CHCl3/MeOH (95 : 5, 0.5 mL) was applied to
the column. Elution with CHCl3, precipitation from highly
concentrated CHCl3 solution with MeOH and subsequent
drying under vacuum aﬀorded the rotaxane 4a (9 mg, 8%) as
a brown powder. Rf¼ 0.35 (PhMe/EtOAc/MeOH 5 : 5 : 1); UV/Vis
(CHCl3): lmax(3) ¼ 428 nm (6.15  103 mol1 dm3 cm1); IR: ~n ¼
3428, 2951, 1726, 1141 cm1. The 1H NMR spectrum of 4a in
CDCl3 at a concentration of 15 mg mL
1 was obtained with low
resolution due to the high level of self-aggregation. Dilution to
2.5 mg mL1 provided an acceptable 1H NMR spectrum with
slightly broadened signals (data given below) and a 13C NMR
spectrum with a low signal-to-noise ratio (see S10;† data not
given); 1H NMR (500 MHz, CDCl3): d¼ 8.41 (s, 2H, M4), 8.13 (d, J
¼ 8.0 Hz, 4H, M2), 7.60 (m, 6H, M1 and NH(M)), 7.26 (s, 8H,
M6), 6.85 (br s, 1H, NH(GABA)), 5.90 (br s, 1H, NH(Gly)), 5.30
(m, 1H, HC(6)), 4.56 (s, 8H, H2C(M)), 4.51 (m, 1H, HC(3)), 4.27
(s, 4H, H2C(pyrr)), 3.06 (br s, 2H, H2C(40)), 2.94 (br s, 2H,
H2C(400)), 2.83 (br s, 2H, H2C(Gly)), 2.54 (t, 1H, J ¼ 8.0 Hz,
HC(17)), 2.25 (m, 2H, H2C(200)), 2.17 (m, 2H, H2C(20), 1.91 (m,
2H, H2C(300)), 2.13 (s, 3H, H3C(21)), 1.66 (m, 2H, H2C(30)), 0.97 (s,
3H, H3C(19)), 0.63 (s, 3H, H3C(18));
1H NMR (500 MHz, [D6]
DMSO + 1 drop of CDCl3): d ¼ 8.84 (m, 4H, NH(M)), 8.31 (s, 2H,
M4)), 7.96 (m, 2H, NH(Gly) and NH(GABA)), 7.91 (d, J ¼ 8.0 Hz,
4H, M2), 7.40 (br t, J¼ 8.0 Hz, 2H, M1), 7.24 (s, 8H, M6), 5.23 (m,
1H, HC(6)), 4.48 (m, 4H, H2C(M)), 4.32 (m, 4H, H2C(M)), 4.29
(m, 1H, HC(3)), 3.66 (s, 2H, H2C(Gly)), 3.38 (s, 4H, H2C(pyrr)),
2.92 (br s, 2H, H2C(40)), 2.05 (m, 2H, H2C(400)), 2.03 (m, 2H,
H2C(20)), 1.88 (m, 2H, H2C(200)), 1.48 (m, 2H, H2C(30)), 1.45 (m,
2H, H2C(300)), 0.91 (m, 1H, HC(9)), 0.86 (s, 3H, H3C(19)), 0.50 (s,
3H, H3C(18));
13C NMR (125 MHz, [D6]DMSO + 1 drop of CDCl3):
d ¼ 208.6 (C(20)), 173.6 (CO(100)), 172.1 (CO(10)), 169.3 (CO(Gly)),
165.7 (CO(M)), Cfull (155.1, 146.8, 146.1, 145.7, 145.5, 145.3,
144.7, 144.1, 142.5, 142.1, 141.9, 141.6, 141.4, 139.4, 135.7),
139.5 (C(5)), 138.1 (C(6)-M), 134.5 (C(3)-M), 130.1 (C(2)-M), 128.8
(C(5)-M), 128.0 (C(1)-M), 126.1 (C(4)-M), 121.9 (C(6)), 73.1
(HC(3)), 69.9 (Cfull-sp
3), 66.2 (C(pyrr)), 62.7 (C(17)), 56.1 (C(14)),
52.9 (C(400)), 49.3 (C(9)), 43.3 (CH2(M)), 43.2 (C(13)), 42.2
(C(Gly)), 38.0 (C(12)), 37.9 (C(40)), 37.5 (C(4)), 36.5 (C(1)), 36.137248 | RSC Adv., 2016, 6, 37246–37253(C(10)), 32.6 (C(20)), 31.4 (C(8), C(7)), 31.2 (C(21)), 27.2 (C(2)),
24.5 (C(300)), 24.1 (C(30)), 22.3 (C(15)), 22.2 (C(16)), 20.6 (C(11)),
19.0 (C(19)), 13.0 (C(18)); HESI-Orbitrap MS (m/z): calcd for
C125H80N7O9 (M + H)
+: 1822.5939, found: 1822.6164.
Rotaxane 4b. A solution of p-xylenediamine (96 mg, 0.701
mmol) in CHCl3 (anhydrous, 15 mL) and a separate solution of
isophthaloyl dichloride (143 mg, 0.701 mmol) in CHCl3 (15 mL)
were added dropwise simultaneously for 4 h to a stirred solution
of the thread 3b (40 mg, 0.047 mmol) and TEA (200 mL, 1.403
mmol) in dry CHCl3 (45 mL) under an atmosphere of Ar. Aer
the addition, the reaction mixture was stirred overnight at
ambient temperature. The mixture was ltered through Celite,
evaporated to dryness and chromatographed on SiO2 by FCC.
The unreacted thread (34 mg, 85%) was eluted with PhMe/
EtOAc/MeOH 10 : 10 : 1 while rotaxane 4b was eluted with
PhMe/EtOAc/MeOH 10 : 10 : 5 and precipitated from DCM
solution with n-hexane. Yield: 8.2 mg (13%); Rf ¼ 0.49 (PhMe/
EtOAc/MeOH 5 : 5 : 1); IR: ~n ¼ 3481, 3439, 3308, 3062, 2942,
2851, 1729, 1701, 1647, 1622, 1535, 1270, 1172, 737 cm1; 1H
NMR (500 MHz, CDCl3): d ¼ 8.33 (s, 2H, M4), 8.14 (dd, J ¼ 1.0
and 8.0 Hz, 4H, M2), 7.58 (t, J ¼ 8.0 Hz, 2H, M1), 7.52 (m, 4H,
NH(M)), 7.22 (s, 8H, M6), 7.10 (br t, J ¼ 5.5 Hz, 1H, NH(GABA)),
5.95 (br t, X part of ABX system, J ¼ 4.0 Hz, 1H, NH(Gly)), 5.29
(m, 1H, HC(6)), 5.21 (m, 1H, HC(6)), 4.64 (m, 4H, H2C(M)), 4.45
(m, 4H, H2C(M)), 4.46 (m, 1H, HC(3)), 4.42 (m, 1H, HC(3)), 3.06
(q, J¼ 6.5 Hz, 2H, H2C(4)-GABA), 2.89 and 2.85 (two AB quartets,
AB part of ABX system, J(AB) ¼ 17 Hz, J(AX, BX) ¼ 4.0 Hz, 2H,
H2C(Gly)), 2.53 (t, J ¼ 9.0 Hz, 2H, HC(17)), 2.32 (br t, J ¼ 6.5 Hz,
2H, H2C(3)-succ), 2.19 (m, 6H, HC(4) and HC(16)), 2.14 (m, 2H,
H2C(2)-GABA), 2.13 (s, 3H, H3C(21)), 2.12 (s, 3H, H3C(21)), 2.09
(br t, J¼ 6.5 Hz, 2H, H2C(2)-succ), 2.06 (m, 2H, HC(12)), 1.98 (m,
2H, HC(7)), 1.79 (m, 2H, HC(1)), 1.70 (m, 2H, HC(2)), 1.67 (m,
2H, HC(15)), 1.66 (m, 4H, HC(16) and H2C(3)-GABA), 1.59 (m,
2H, HC(11)), 1.55 (m, 2H, HC(7)), 1.49 (m, 2H, HC(2)), 1.46 (m,
2H, HC(11)), 1.45 (m, 4H, HC(8) and HC(12)), 1.23 (m, 2H,
HC(15)), 1.15 (m, 2H, HC(14)), 0.99 (m, 2H, HC(1)), 0.97 (m, 2H,
HC(9)), 0.95 (s, 6H, H3C(19)), 0.62 (s, 6H, H3C(18));
13C NMR
(125 MHz, CDCl3): d ¼ 209.6 (C(20)), 172.8 (CO-succ, ester),
172.5 (CO-GABA), 172.2 (CO-succ, amide), 169.1 (CO-Gly), 166.5
(CO-M), 139.2, 139.0 (C(5)), 137.7 (C(6)-M), 133.9 (C(3)-M), 131.5
(C(2)-M), 129.2 (C(1)-M), 129.1(C(5)-M), 124.0 (C(4)-M), 122.7
and 122.6 (C(6)), 74.8 and 74.4 (C(3)), 63.6 (C(17)), 56.8 (C(14)),
49.8 and 49.7 (C(9)), 44.1 (H2C-M), 44.0 (C(13)), 42.4 (C(Gly)),
39.2 (C(4)-GABA), 38.7 (C(12)), 37.9 (C(4)), 36.8 and 36.7 (C(1)),
36.5 (C(10)), 31.7 (C(7), C(8), C(20)), 31.5 (C(2)-GABA), 30.1 (C(2)-
succ), 29.7 (C(3)-succ), 27.7 and 27.6 (C(2)), 24.5 (C(15)), 24.3
(C(3)-GABA), 22.8 (C(16)), 21.0 (C(11)), 19.2 (C(19)), 13.2 (C(18));
the unthreading of the rotaxane 4b started immediately aer
dissolution in [D6]DMSO, so the corresponding
1H and 13C
chemical shis were determined by comparative analysis of the
NMR data of the sample, pure thread 3b and pure M. 1H NMR
(500 MHz, [D6]DMSO): d ¼ 8.60 (br q, J ¼ 5.0 Hz, 4H, NH(M)),
8.15 (s, 2H, M4), 7.94 (dd, J¼ 1.5 and 8.0 Hz, 4H, M2), 7.86 (br t,
J ¼ 5.5 Hz, 1H, NH(Gly)), 7.64 (br t, J ¼ 5.5 Hz, 1H, NH(GABA)),
7.54 (t, J¼ 7.5 Hz, 2H, M1), 7.16 (s, 8H, M6), 5.16 (m, 1H, HC(6)),
5.12 (m, 1H, HC(6)), 4.39 (m, 4H, H2C(M)), 4.32 (m, 4H,
H2C(M)), 4.12 (m, 1H, HC(3)), 3.99 (m, 1H, HC(3)), 3.38 (J ¼ 5.5This journal is © The Royal Society of Chemistry 2016
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View Article OnlineHz, 2H, H2C(Gly)), 2.58 (q, J ¼ 6.0 Hz, 2H, H2C(4)-GABA), 2.54
(br t, J ¼ 9.0 Hz, 2H, HC(17)), 2.10 (m, 4H, H2C(2)-succ and
H2C(3)-succ), 2.04 (s, 3H, H3C(21)), 1.99 (m, 2H, HC(16)), 1.95
(m, 2H, HC(12)), 1.86 (m, 2H, HC(7)), 1.76 (m, 4H, HC(4)), 1.73
(m, 2H, H2C(2)-GABA), 1.62 (m, 2H, HC(1)), 1.57 (m, 2H,
HC(15)), 1.54 (m, 2H, HC(16)), 1.48 (m, 2H, HC(11)), 1.45 (m,
2H, HC(7)), 1.38 (m, 2H, HC(12)), 1.31 (m, 4H, HC(8) and
HC(12)), 1.22 (m, 2H, HC(2)), 1.18 (m, 2H, H2C(3)-GABA), 1.10
(m, 4H, HC(14) and HC(15)), 0.99 (m, 2H, HC(2)), 0.82 (m, 2H,
HC(9)), 0.81 (s, 3H, H3C(19)), 0.78 (m, 2H, HC(1)), 0.75 (s, 3H,
H3C(19)), 0.49 (s, 6H, H3C(18));
13C NMR (125 MHz, [D6]DMSO):
d ¼ 208.9 (C(20)), 172.3 (CO(GABA)), 172.1 (CO-succ, ester),
171.9 (CO-succ, amide), 169.0 (CO(Gly)), 166.0 (CO-M), 139.5
(C(5)), 137.7 (C(6)-M), 134.6 (C(3)-M), 130.1 (C(2)-M), 128.7 (C(1)-
M), 128.5 (C(5)-M), 126.1 (C(4)-M), 121.8, 121.7 (C(6)), 73.3 and
73.0 (C(3)), 62.7 (C(17)), 56.1 (C(14)), 49.3 (C(9)), 43.2 (H2C-M),
42.8 (C(13)), 42.1 (C(Gly)), 38.0 (C(12)), 37.8 (C(4)-GABA), 37.3
and 37.1 (C(4)), 36.5 (C(1)), 36.1 (C(10)), 31.4 (C(8) and (C(7)),
31.3 (C(21)), 31.0 (C(2)-GABA), 29.7 (C(2)-succ), 28.9 (C(3)-succ),
27.0 and 26.8 (C(2)), 24.3 (C(3)-GABA), 24.1 (C(15)), 22.4 (C(16)),
20.6 (C(11)), 19.0 and 18.9 (C(19)), 13.0 (C(18)). HRMS (ESI-TOF)
(m/z): calcd for C84H105N6O12 (M + H)
+: 1389.7785, found:
1389.7765.3. Results and discussion
Target compounds were prepared according to Scheme 1
considering the observation that labile hydrogen bonding in
rotaxanes allows solvent-induced molecular motion.9a,b Hereof,
the presence of the GABA-Gly-GABA diamide fragment and
suitable bulky terminal subunits in the previously synthesized,
quite soluble fullerene-peptide-steroid triad 3a19 generated an
optimal thread for the unsymmetrical, fullerene-steroid-
stoppered molecular shuttle. By analogy, a Succ-Gly-GABA
component as the molecular recognition core as well as preg-
nenolone subunits as endpoints were used to design the threadScheme 1 Synthesis of fullerosteroidal and disteroidal rotaxanes 4 with
This journal is © The Royal Society of Chemistry 20163b for a steroid-stoppered, interlocked system. The new
compound 3bwas prepared analogous to 3a, following the DCC/
HOBT assisted amidation of the amine-TFA salt 1 using preg-
nenolone hemisuccinate 2b in the presence of triethylamine in
dichloromethane. Following the Leigh procedure,22 iso-
phthaloyl dichloride and p-xylylenediamine were simulta-
neously added to a solution of the corresponding threads 3.
Their diamide GABA-Gly-GABA and GABA-Gly-Succ subunits,
containing two amide carbonyl functions in the 1,4-position,
templated the macrocycle clipping around the axes, providing
rotaxanes 4. The careful ash column chromatography (FCC) of
the crude, unsymmetrically stoppered, non-covalent hybrid on
SiO2 gave a mixture of rotaxane 4a and the free tetraamide
macrocycle (M). The conditions for their purication by chro-
matography on silica gel were not found, since both compounds
showed equal Rf values in many applied eluents (numerous
binary and ternary mixtures of CHCl3, PhMe, EtOAc and
MeOH). The favorable p–p interactions between the free mac-
rocycle and the outer side of the fullerene subunit might be
a reason for unsuccessful separation on the silica column.
Nevertheless, pure rotaxane 4a was obtained by gel ltration on
Sephadex G-25 in CHCl3, subsequent precipitation from CHCl3
solution with MeOH and drying in a vacuum oven for two days
(45 C, 15 mbar). In the NMR spectrum in CDCl3, signals cor-
responding to poorly soluble free M did not appear, while in
[D6]DMSO diluted with one drop of CDCl3 (1 drop of CDCl3 was
necessary to completely dissolve the mixture 4a/M) they were
clearly visible, providing a way to check unambiguously the
purity of rotaxane 4a.
In contrast, a careful FCC of the disteroidal rotaxane 4b
proceeded smoothly, providing a pure target compound.
Although performing hydrogen bond-templated interlocking
aﬀorded rotaxanes in quite a moderate yield (Scheme 1), their
precursors were successfully recovered (80% of 3a and 85% of
3b) and reused. In addition to the structural requirements, the
achieved yield might be attributed to the poor solubility ofa tetraamide macrocycle.
RSC Adv., 2016, 6, 37246–37253 | 37249
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View Article Onlinethread precursors and the unthreading process in the presence
of polar medium during column chromatography.
The structures of all compounds were determined from IR,
NMR (1H, 13C, COSY, HSQC and HMBC) and HRMS spectra
supported also by the UV/Vis data of the fullerene containing
thread 3a and rotaxane 4a. The presence of a steroidal moiety in
the rotaxane 4a signicantly improved its solubility in chloro-
form, but concentrations higher than 1.4 mM (2.5 mg mL1,
used for 1H NMR recording) led to solution jellication, indi-
cating the compounds self-aggregate. Also, in the 13C NMR
spectrum in CDCl3 no response for thread carbonyls was
observed, while [D6]DMSO (with addition of one drop of CDCl3)
enabled assignment of all carbons. Comparison of the 1H NMR
spectra of rotaxanes 4 and the corresponding threads 3 in CDCl3
(Fig. 1) aﬃrmed the interlocked architecture anchored by
hydrogen bonds between the four macrocyclic amide H and the
two amide carbonyl oxygen atoms. The location of the macro-
cycle on the diamide station (GABA-Gly-GABA in 4a and Succ-Gly-
GABA in 4b, Scheme 2) was clearly determined from the chem-
ical shi diﬀerences of the pyrrolidine, amide and steroid
protons in rotaxanes and corresponding threads (Fig. 1, Tables
S1 and S2 in ESI†).
Thus, as a result of the anisotropic eﬀect of the macrocycle
aromatic rings, both methylene and amide Gly protons of
rotaxanes 4 are signicantly upeld shied in comparison to
threads 3 (Dd  1 ppm for CH2; 1.0 and 0.5 ppm for NH of 4a
and 4b, respectively). Somewhat weakened shielding of protons
near the Gly N-side resulted in lesser shiing of 0.4 ppm
(GABA 200, 300 and Succ 2, 3 in 4a and 4b, respectively, Tables S1
and S2†). The smallest diﬀerence (up to 0.2 ppm) in the
chemical shis of the remaining signals belonging to the pyr-
rolidine ring, the rest of GABA and characteristic steroidal
protons (H-3, H-6 and the angular methyl groups) conrmed the
position of the macrocycle around the diamide binding site, as
shown in Scheme 2. In addition, diverse shielding of the
steroidal stoppers by the macrocycle aromatic rings led to the
splitting of the olenic H-6 signal (Fig. 1c and d and 2d and e).Fig. 1 Partial 1H NMR spectra (500 MHz, CDCl3) of (a) thread 3a, (b)
rotaxane 4a, (c) thread 3b, and (d) rotaxane 4b. Labels correspond to
those indicated in Scheme 2.
37250 | RSC Adv., 2016, 6, 37246–37253Samples of both rotaxanes were kept in CDCl3 solution for
a week at room temperature with no NMR evidence of macro-
cycle release.
Exposing these compounds to solvents possessing strong H-
bond accepting properties, such as DMSO, induced macrocycle
shuttling along the corresponding threads. Thanks to the
fullerene stopper and the resulting p–p interactions with four
aromatic rings of the wheel,9a,b the mechanically interlocked
architecture of rotaxane 4a was mainly preserved, while under
the same conditions, the disteroidal analogue 4b appeared less
stable. A striking upeld shi of the pyrrolidinic signal of
rotaxane 4a in DMSO (d 3.38 ppm, Fig. 2b) in comparison to the
same structure in CDCl3 (d 4.27 ppm, Fig. 1b), as well as to
thread 3a in DMSO (d 4.45 ppm, Fig. 2a), was noticed, indicating
wheel displacement to the fullerene proximity (see also Table
S1†). Also, the resonances associated with methylene protons
belonging to the GABA moiety adjacent to the pyrrolidine (200–
400, Scheme 2) followed the same trend. Observed shis
(reducing the distance from the C60 moiety) additionally sup-
ported the macrocycle position (Fig. 2a–c and Table S1†) and
formation of the stacked co-conformer of 4a in [D6]DMSO
(Scheme 2). The resonance of macrocycle benzylic protons
(CH2(M)) appeared as a broad singlet only in rotaxane 4a in
CDCl3 (Fig. 1b), indicating their fast exchange. The signal
splitting (two multiplets for AB part of ABX system) in rotaxane
4b in CDCl3 (Fig. 1d) and in both rotaxanes in [D6]DMSO
(Fig. 2b and e) supports its reduced symmetry and indicates
slow rotation of the macrocycle around the thread on the NMR
time scale at room temperature.
In order to monitor shuttling processes in more detail, 1H
NMR titration of rotaxane 4a in CDCl3 with [D6]DMSO was
performed (Fig. 3). As can be seen, the rst addition of [D6]
DMSO (1%, Fig. 3b) led to complete solvation of the GABA-
amide proton provoking its strong downeld shi from d 6.85
to 7.79 ppm, practically to the value observed for the free thread.
In such conditions the chemical shi of the Gly amide proton
was not changed, probably due to sterically hindered solvent
access. A gradual increase of the medium polarity induced the
progressive breakage of the wheel-thread H-bonds and the
solvation of the macrocycle amide protons (NH(M)), leading to
their deshielding of almost 1 ppm – from d 7.79 ppm in the
presence of 1% [D6]DMSO to d 8.76 ppm in the mixture con-
taining 52% [D6]DMSO (Fig. 3b–i). Aer addition of 15% [D6]
DMSO (Fig. 3f), several changes in the 1H NMR spectrum were
observed, all together suggesting the parallel existence of mac-
rocycle conformational changes and solvation of Gly-NH. Thus,
a broad singlet of CH2(M) changed to two multiplets and the
CHPyrr2 singlet was slightly shied upeld (Dd  0.2 ppm), while
Gly-NH proton was shied downeld (Dd 0.8 ppm). A low level
of unthreading was rst detected with 42% [D6]DMSO, resulting
in the appearance of weak signals corresponding to the free
thread as well as the macrocycle (Fig. 3h). Increasing the
medium polarity to 52% [D6]DMSO led to the upeld shi of the
pyrrolidine singlet to d < 3.70 (overlapped with water signal) and
further deshielding of both amide protons (Fig. 3i), indicating
macrocycle motion preferentially toward the fullerene stopper
and formation of the stable stacked co-conformer (Scheme 2).This journal is © The Royal Society of Chemistry 2016
Scheme 2 Solvent-induced translocation of the macrocyclic ring (M) with the proposed structures of co-conformers followed by partial and
complete dissociation of rotaxanes 4a and 4b, respectively.
Fig. 2 Partial 1H NMR spectra (500 MHz, [D6]DMSO) of (a) thread 3a,
(b) rotaxane 4a immediately after dissolution, (c) rotaxane 4a after 24 h,
(d) thread 3b, (e) rotaxane 4b immediately after dissolution, (f) rotaxane
4b after 24 h, and (g) free macrocycle M. For labels, see Scheme 2.
Fig. 3 1H NMR monitoring of macrocycle translocation in the rotax-
ane 4a in CDCl3 (a) induced by [D6]DMSO (b: 1%, c: 2%, d: 4%, e: 8%, f:
15%, g: 30%, h: 42%, i: 52%).
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View Article OnlineNo signicant dissociation of fullerosteroidal rotaxane 4a in
[D6]DMSO was detected over 24 h (2 and 10% aer 1 and 24 h,
respectively), while aer 7 days in the same solvent 25% of the
mechanically interlocked system underwent unthreading. In
contrast, rigid but not suﬃciently bulky pregnenolone units in
the steroidal rotaxane 4b allowed the macrocycle to slip over
them, enabling amuch faster dissociation process (4% aer 1 h,
100% aer 24 h). In such a case, many intermediate steroid co-This journal is © The Royal Society of Chemistry 2016conformers (Scheme 2) might be suggested. Due to the fast
unthreading in a polar solvent at room temperature, in such
conditions the supramolecular assembly 4b could be consid-
ered as a pseudorotaxane.
Previously reported results conrming organogelation
behaviour of the fullerene–cholesterol conjugate23 and
cholesterol-stoppered rotaxane,18 prompted us to examine the
self-organization properties of synthesized rotaxanes 4. To that
purpose, the solubility in individual solvents (CHCl3, PhMe,
THF, dioxane and EtOAc) and their binary mixtures wasRSC Adv., 2016, 6, 37246–37253 | 37251
Fig. 4 SEM images of (a) rotaxane 4a (0.1 mM in CHCl3), (b) rotaxane
4b (0.1 mM in PhMe/EtOAc ¼ 1 : 1), and (c) photo of 4b gel (1 mM in
PhMe/EtOAc ¼ 1 : 1).
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View Article Onlinechecked, while the form of the aggregates obtained aer solvent
evaporation was followed by scanning electron microscopy
(SEM). The presence of the fullerene moiety in rotaxane 4a
reduced its solubility, aﬀording a clear solution only in chlo-
roform. The jellication noticed at higher concentration (1.4
mM) during NMR recording indicated reorganization at the
supramolecular level. The direct evidence for the tendency for
self-ordering was obtained by SEM, the image of which revealed
the association of quite uniform, round structures to
micrometer-sized elongated particles (Fig. 4a). As expected,
both disteroidal structures (thread 3b and rotaxane 4b) were
easily soluble in all media used. However, unlike compound 3b,
aer few minutes at room temperature a clear 1 mM solution of
4b in PhMe/EtOAc 1 : 1 mixture was transformed into trans-
parent gel, stable up to 50 C (Fig. 4c). Prolonged drying of
a drop of 0.1 mM solution allowed organization of 4b into
a branched lm-like network (Fig. 4b) or into irregularly shaped
large microstructures in the case of 3b (Fig. S1 in ESI†), con-
rming their diﬀerent aﬃnities for aggregation. The observed
diﬀerence in the gelation ability between the disteroidal thread
3b and the corresponding rotaxane 4b strongly indicates that
hydrogen bonding interactions of the mechanically interlocked
structure plays an important role in self-assembly, thereby
controlling the gelation process.4. Conclusions
Two novel hydrogen-bond assembled fullerosteroidal and dis-
teroidal[2]rotaxanes are synthesized by GABA-Gly-GABA and
Succ-Gly-GABA templated macrocycle clipping over the axles
containing corresponding stoppers. 1H NMR spectroscopy was
used to investigate solvent-induced macrocycle movement
along the threads, as well as the stability of the interlocked
architectures, expressed as the aﬃnity for unthreading. The
target compounds have proven to be stable in a non polar
environment (CDCl3) regardless of the stopper nature, occu-
pying the peptide co-conformation with the macrocycle
anchored by the axle–wheel interamide H-bonds. In the case of
the fullerene-stoppered rotaxane 4a, the solvation of amide
groups by [D6]DMSO caused macrocycle translocation toward
the fullerene and formation of a quite stable stacked co-
conformer, stabilized by wheel-stopper p–p interactions. In
contrast, rigid steroidal moieties turned out to be insuﬃciently
bulky to protect the macrocycle from slipping, leading to prac-
tically quantitative unthreading of the disteroidal rotaxane 4b37252 | RSC Adv., 2016, 6, 37246–37253aer 24 h. In addition, both rotaxanes expressed a strong
tendency to self-order, while a rotaxane with terminal preg-
nenolone units also showed organogelation behaviour. Based
on their dynamic properties, these novel supramolecular
architectures could be of use for designing new interlocked
systems with controlled dissociation in polar medium.Acknowledgements
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